Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 14
157
Views
1
CrossRef citations to date
0
Altmetric
Short Communication

Supercritical carbon-oxide extracts from cultivated and wild-grown Ganoderma lucidum mushroom: differences in ergosterol and ganoderic acids content, antioxidative and enzyme inhibitory properties

, , &
Pages 2522-2528 | Received 08 Sep 2022, Accepted 23 Jan 2023, Published online: 06 Feb 2023

References

  • Bellettini MB, Fiorda FA, Maieves HA, Teixeira GL, Ávila S, Hornung PS, Junior AM, Ribani RH. 2019. Factors affecting mushroom Pleurotus spp. Saudi J Biol Sci. 26(4):633–646.
  • Bibi NB, Montesano D, Albrizio S, Zengin G, Mahomoodally MF. 2020. The versatility of antioxidant assays in food science and safety-Chemistry, applications, strengths, and limitations. Antioxidants. 9:1–39.
  • Boyden S. 1973. Evolution and health. Ecologist. 3:304–309.
  • Cao L, Jin H, Liang Q, Yang H, Li S, Liu Z, Yuan Z. 2022. A new anti-tumor cytotoxic triterpene from Ganoderma lucidum. Nat Prod Res. 36(16):4125–4131.
  • Carrieri R, Manco R, Sapio D, Iannaccone M, Fulgione A, Papaianni M, de Falco B, Grauso L, Tarantino P, Ianniello F, et al. 2017. Structural data and immunomodulatory properties of a water-soluble heteroglycan extracted from the mycelium of an Italian isolate of Ganoderma lucidum. Nat Prod Res. 31(18):2119–2125.
  • Chen S, Yong T, Zhang Y, Su J, Jiao C, Xie Y. 2017. Anti-tumor and anti-angiogenic ergosterols from Ganoderma lucidum. Front Pharmacol. 5:1–12.
  • Ćilerdžić JL, Sofrenić IV, Tešević VV, Brčeski ID, Duletić‐Laušević SN, Vukojević JB, Stajić MM. 2018. Neuroprotective potential and chemical profile of alternatively cultivated Ganoderma lucidum basidiocarps. Chem Biodivers. 15(5):e1800036.
  • Cor D, Botic T, Knez Z, Batista U, Gregori A, Pohleven F, Boncina T. 2014. Two-stage extraction of antitumor, antioxidant and antiacetylcholinesterase compounds from Ganoderma lucidum fruiting body. J Supercrit Fluids. 91:53–60.
  • Hadda M, Djamel C, Akila O. 2015. Production and qualitative analysis of triterpenoids and steroids of Ganoderma species harvested from cork oak forest of North-Eastern Algeria. Res J Microbiol. 10(8):366–376.
  • Hasnat MD, Pervin M, Lim BO. 2013. Acetylcholinesterase inhibition and in vitro and in vivo antioxidant activities of Ganoderma lucidum grown on germinated brown rice. Molecules. 18(6):6663–6678.
  • Hatami T, Johner JCF, Zabot GL, Angela M, Meireles A. 2019. Supercritical fluid extraction assisted by cold pressing from clove buds: extraction performance, volatile oil composition, and economic evaluation. J Supercrit Fluids. 144:39–47.
  • Hsu RC, Lin BH, Chen CW. 2001. The study of supercritical carbon dioxide extraction for Ganoderma lucidum. Ind Eng Chem Res. 40(20):4478–4481.
  • Johner JCF, Hatami T, Zabot GL, Angela M, Meireles A. 2018. Kinetic behavior and economic evaluation of supercritical fluid extraction of oil from pequi (Caryocar brasiliense) for various grinding times and solvent flow rates. J Supercrit Fluids. 140:188–195.
  • Kaur A, Randhawa K, Singh V, Shri R. 2019. Bioactivity-guided isolation of acetylcholinesterase inhibitor from Ganoderma mediosinense (Agaricomycetes. Int J Med Mushrooms. 21(8):755–763.
  • Keypour S, Rafati H, Riahi H, Mirzajani F, Moradali MF. 2010. Qualitative analysis of ganoderic acids in Ganoderma lucidum from Iran and China by RP-HPLC and electrospray ionisation-mass spectrometry (ESI-MS). Food Chem. 119(4):1704–1708.
  • Kikuchi T, Kanomi S, Murai Y, Kadota S, Tsubono K, Ogita ZI. 1986. Constituents of the fungus Ganoderma lucidum (Fr.) Karst. III Structures of ganolucidic acids A and B, new lanostane-type triterpenoids. Chem Pharm Bull. 34(10):4030–4036.
  • Koo MH, Chae HJ, Hyuck JL, Suh SS, Youn UJ. 2021. Antiinflammatory lanostane triterpenoids from Ganoderma lucidum. Nat Prod Res. 35(22):4295–4302.
  • Krupodorova TA, Barshteyn VY, Kızıtska TO, Pokas EV. 2019. Effect of cultivation conditions on mycelial growth and antibacterial activity of Lentinula edodes and Fomitopsis betulina. Czech Mycol. 7:167–186.
  • Li C, Li Y, Sun HH. 2006. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Nat Prod Res. 20(11):985–991.
  • Li C, Yin J, Guo F, Zhang D, Sun HH. 2005. Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Nat Prod Res. 19(5):461–465.
  • Li D, Leng Y, Liao Z, Hu J, Sun Y, Deng S, Wang C, Tian X, Zhou J, Wang R. 2022. Nor-triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH. Nat Prod Res. 24:1–7.
  • Li J, Zhang X, Liu Y. 2016b. Supercritical carbon dioxide extraction of Ganoderma lucidum spore lipids. LWT – Food Sci Technol. 70:16–23.
  • Li L, Guo HJ, Zhu LY, Zheng L, Liu X. 2016a. A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial–mesenchymal transition. Phytomedicine. 23(5):491–497.
  • Li P, Deng YP, Wei XX, Xu JH. 2013. Triterpenoids from Ganoderma lucidum and their cytotoxic activities. Nat. Prod. Res. 27(1):17–22.
  • Lu H, Lou H, Hu J, Liu Z, Chen Q. 2020. Macrofungi: a review of cultivation strategies, bioactivity, and application of mushrooms. Compr Rev Food Sci Food Saf. 19(5):2333–2356.
  • Lv GP, Zhao J, Duan JA, Tang YP, Li SP. 2012. Comparison of sterols and fatty acids in two species of Ganoderma. Chem Cent J. 6(1):10–18.
  • Manjare SD, Dhingra K. 2019. Supercritical fluids in separation and purification: a review. Mater Sci Technol. 2:463–484.
  • Rašeta M, Popović M, Beara I, Šibul F, Zengin G, Krstić S, Karaman M. 2021. Anti‐Inflammatory, antioxidant and enzyme inhibition activities in correlation with mycochemical profile of selected indigenous Ganoderma spp., from Balkan Region (Serbia). Chem Biodiver. 18:e2000828.
  • Ruan W, Hiang A, Lim H, Huang LG, Popovich DG. 2014. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth. Nat Prod Res. 28(24):2264–2272.
  • Sułkowska-Ziaja K, Zengin G, Gunia-Krzyżak A, Popiół J, Szewczyk A, Jaszek M, Rogalski J, Muszyńska B. 2022. Bioactivity and mycochemical profile of extracts from mycelial cultures of Ganoderma spp. Molecules. 27(1):275.
  • Taofiq O, Heleno SA, Calhelha RC, Alves MJ, Barros L, Gonzalez-Param AM, Barreiro MF, Ferreira ICFR. 2017. The potential of Ganoderma lucidum extracts as bioactive ingredients in topical formulations, beyond its nutritional benefits. Food Chem Toxicol. 108(Pt A):139–147.
  • Venditti KA, Frezza C, Sciubba F, Serafini M, Bianco A. 2017. Primary and secondary metabolites of an European edible mushroom and its nutraceutical value: suillus bellinii (Inzenga). Nat Prod Res. 31(16):1910–1919.
  • Wang J, Ke R, Zhang S. 2017. Breaking the sporoderm of Ganoderma lucidum spores by combining chemical reaction with physical actuation. Nat Prod Res. 31(20):2428–2434.
  • Wang L, Li JQ, Zhang J, Li ZM, Liu HG, Wang YZ. 2020. Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review. RSC Adv. 10:42084–42097.
  • Wang XM, Yang M, Guan SH, Liu RX, Xia JM, Bi KS, Guo DA. 2006. Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. J Pharm Biomed Anal. 41(3):838–844.
  • Wu M, Shen CE, Lin QF, Zhong JY, Zhou YF, Liu BC, Xu JH, Zhang ZQ, Peng L. 2022. Sterols and triterpenoids from Ganoderma lucidum and their reversal activities of tumor multidrug resistance. Nat Prod Res. 36(5):1396–1399.
  • Ye WY, Wang JZ, Deng GG, Dang YW, Liu HW, Chen G. 2021. Estrogenic activities of compound GL-1, isolated from Ganoderma lucidum. Nat Prod Res. 35(24):6062–6066.
  • Zengin G, Sarikurkcu C, Gunes E, Uysa A, Ceylan R, Uysal S, Gungor H, Aktumsek A. 2015. Two Ganoderma species: profiling of phenolic compounds by HPLC–DAD, antioxidant, antimicrobial and inhibitory activities on key enzymes linked to diabetes mellitus, Alzheimer‘s disease and skin disorders. Food Funct. 6(8):2794–2802.
  • Zhang CR, Yang SP, Yue JM. 2008. Sterols and triterpenoids from the spores of Ganoderma lucidum. Nat Prod Res. 22(13):1137–1142.
  • Zhang XQ, Ip FCF, Zhang DM, Chen LX, Zhang W, Li YL, Ip NY, Ye WC. 2011. Triterpenoids with neurotrophic activity from Ganoderma lucidum. Nat Prod Res. 25(17):1607–1613.
  • Zhu L, Wu M, Li P, Zhou Y, Zhong J, Zhang Z, Li Y, Yao W, Xu J. 2020. High-pressure supercritical CO2 extracts of Ganoderma lucidum fruiting body and their anti-hepatoma effect associated with the Ras/Raf/MEK/ERK signaling pathway. Front Pharmacol. 11:602702–602702.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.